Literature DB >> 20652782

TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins.

Elisabeth Paus1, Mads Haugland Haugen, Kari Hauge Olsen, Kjersti Flatmark, Gunhild Mari Maelandsmo, Olle Nilsson, Eva Röijer, Maria Lundin, Christian Fermér, Maria Samsonova, Yuri Lebedin, Torgny Stigbrand.   

Abstract

Fourteen monoclonal antibodies with specificity against native or recombinant antigens within the S100 family were investigated with regard to immunoreactivity. The specificities of the antibodies were studied using ELISA tests, Western blotting epitope mapping using competitive assays, and QCM technology. The mimotopes of antibodies against S100A4 were determined by random peptide phage display libraries. Antibody specificity was also tested by IHC and pair combinations evaluated for construction of immunoradiometric assays for S100B. Out of the 14 antibodies included in this report eight demonstrated specificity to S100B, namely MAbs 4E3, 4D2, S23, S53, 6G1, S21, S36, and 8B10. This reactivity could be classified into four different epitope groups using competing studies. Several of these MAbs did display minor reactivity to other S100 proteins when they were presented in denatured form. Only one of the antibodies, MAb 3B10, displayed preferential reactivity to S100A1; however, it also showed partial cross-reactivity with S100A10 and S100A13. Three antibodies, MAbs 20.1, 22.3, and S195, were specific for recombinant S100A4 in solution. Western blot revealed that MAb 20.1 and 22.3 recognized linear epitopes of S100A4, while MAb S195 reacted with a conformational dependent epitope. Surprisingly, MAb 14B3 did not demonstrate any reactivity to the panel of antigens used in this study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20652782     DOI: 10.1007/s13277-010-0073-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  29 in total

1.  The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study.

Authors:  T Ingebrigtsen; B Romner; S Marup-Jensen; M Dons; C Lundqvist; J Bellner; C Alling; S E Børgesen
Journal:  Brain Inj       Date:  2000-12       Impact factor: 2.311

2.  Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction.

Authors:  M Grigorian; S Andresen; E Tulchinsky; M Kriajevska; C Carlberg; C Kruse; M Cohn; N Ambartsumian; A Christensen; G Selivanova; E Lukanidin
Journal:  J Biol Chem       Date:  2001-03-05       Impact factor: 5.157

3.  Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor.

Authors:  Maria Rosario Fernandez-Fernandez; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

4.  Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest.

Authors:  H Rosén; L Rosengren; J Herlitz; C Blomstrand
Journal:  Stroke       Date:  1998-02       Impact factor: 7.914

5.  S100B protein detection in serum is a significant prognostic factor in metastatic melanoma.

Authors:  A Hauschild; G Engel; W Brenner; R Gläser; H Mönig; E Henze; E Christophers
Journal:  Oncology       Date:  1999       Impact factor: 2.935

6.  CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family.

Authors:  Anna Filipek; Beata Jastrzebska; Marcin Nowotny; Jacek Kuznicki
Journal:  J Biol Chem       Date:  2002-05-31       Impact factor: 5.157

Review 7.  Biological and methodological features of the measurement of S100B, a putative marker of brain injury.

Authors:  Carlos-Alberto Gonçalves; Marina Concli Leite; Patrícia Nardin
Journal:  Clin Biochem       Date:  2008-04-18       Impact factor: 3.281

8.  Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma.

Authors:  T Bánfalvi; K Gilde; M Gergye; M Boldizsár; T Kremmer; S Ottó
Journal:  Eur J Cancer       Date:  2003-01       Impact factor: 9.162

9.  Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles.

Authors:  C Arcuri; I Giambanco; R Bianchi; R Donato
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

10.  A new specific method for measuring S-100B in serum.

Authors:  T Stigbrand; L Nyberg; A Ullén; K Haglid; E Sandström; J Brundell
Journal:  Int J Biol Markers       Date:  2000 Jan-Mar       Impact factor: 3.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.